Geneos Wealth Management Inc. Amicus Therapeutics, Inc. Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 850 shares of FOLD stock, worth $7,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
850
Previous 697
21.95%
Holding current value
$7,114
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FOLD
# of Institutions
301Shares Held
331MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$246 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$244 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$204 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$151 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$123 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.35B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...